Tag: Angioedema Companies

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Angioedema Treatment Market From 2025 To 2034?

The angioedema treatment market size has seen rapid growth in recent years. It is anticipated to expand from $2.72 billion in 2024 to $3.13 billion in 2025, with a compound annual growth rate (CAGR) of 15.0%. The expansion during the historic period can be linked to increasing government support, a rise in diagnosis rates, a rise in autoimmune disorders, growth in clinical trials, and growth in healthcare infrastructure.

The angioedema treatment market is projected to experience substantial expansion in the next few years, with its size expected to reach $5.4 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.6%. This anticipated growth is attributed to factors such as increasing healthcare expenditure, heightened awareness regarding allergies, the rising prevalence of chronic diseases, an elevated incidence and prevalence of angioedema, and a growing emphasis on personalized medicine. Key trends shaping the market during this forecast period include advancements in diagnostic technologies, the integration of machine learning, significant investments in research and development, wider adoption of telemedicine, and streamlined regulatory approvals enabling faster market access.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24460&type=smp

What Are The Key Drivers Of Growth In The Angioedema Treatment Market?

The angioedema treatment market is projected to expand due to the growing occurrence of rare diseases. These are medical conditions impacting a small segment of the population, frequently characterized by limited therapeutic options and considerable health consequences. The frequency of rare diseases is on the rise, attributed to improvements in genetic screening and diagnostic tools. These innovations empower medical professionals to identify and precisely diagnose conditions previously undetected, resulting in an elevated reported prevalence. Angioedema treatment offers vital support for rare conditions, including hereditary angioedema, by delivering specific therapies that aid in averting and controlling severe swelling incidents, thus enhancing patient results. For instance, in November 2024, as reported by the Food and Drug Administration, a US-based federal agency, over 7,000 rare diseases affected more than 30 million individuals in the United States. Consequently, the increasing incidence of rare diseases is fueling the expansion of the angioedema treatment market.

What Are The Leading Segments Analyzed In The Angioedema Treatment Market?

The angioedema treatment market covered in this report is segmented –

1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema

2) By Route Of Administration: Injection, Oral

3) By End Use: Hospitals, Clinics, Research Organizations

1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies

2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors

3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management

4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics

Which Trends Are Impacting The Angioedema Treatment Market?

Leading companies in the angioedema treatment market are concentrating on creating advanced solutions, including subcutaneous injections, to provide more convenient and swift relief for individuals suffering from acute hereditary angioedema (HAE) attacks. Subcutaneous injections are a method where medication is delivered into the fatty tissue just beneath the skin for gradual and consistent absorption into the bloodstream. For instance, in April 2025, CSL Limited, an Australia-based biotechnology company, launched ANDEMBRY (garadacimab), which is a novel, fully human monoclonal antibody treatment aimed at preventing acute attacks in patients with hereditary angioedema (HAE). ANDEMBRY is distinguished as the first pre-filled pen for once-monthly subcutaneous administration, offering a convenient option for long-term prophylaxis. This drug functions by inhibiting activated Factor XII (Factor XIIa), a critical initiator in the biochemical pathway leading to angioedema. It represents a significant advancement in HAE management, delivering effective and patient-centric disease control.

Who Are The Key Multinational Companies Dominating The Angioedema Treatment Market?

Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/angioedema-treatment-global-market-report

What Are The Regional Market Dynamics Impacting The Angioedema Treatment Industry?

North America was the largest region in the angioedema treatment market in 2024. The regions covered in the angioedema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Angioedema Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24460&type=smp

Browse Through More Reports Similar to the Global Angioedema Treatment Market 2025, By The Business Research Company

Hereditary Angioedema Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hereditary-angioedema-therapeutics-global-market-report

Retinal Vein Occlusion Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/retinal-vein-occlusion-treatment-global-market-report

Angina Pectoris Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Angioedema Treatment Market Valued at Present and by 2029?

In recent times, the market size for angioedema treatment has witnessed swift growth. The prediction is that the market will expand from a value of $2.72 billion in 2024 to $3.13 billion in 2025, showing a compound annual growth rate (CAGR) of 15.0%. The historical growth was fueled by multiple factors including enhanced government support, increased rates of diagnosis, a greater number of autoimmune disorders, an increase in clinical trials, and expansion in healthcare infrastructure.

Expectations are high for a swift escalation in the angioedema treatment market size in the imminent years. The market is projected to reach a value of $5.4 billion by 2029, with a compound annual growth rate (CAGR) of 14.6%. The forecasted expansion in this period is correlated with factors such as an upsurge in healthcare spending, heightened awareness of allergies, surge in chronic disease occurrence, increased incidence and prevalence of angioedema, and an intensified focus on personalized medicine. During the forecast period, several significant trends are anticipated, including progress in diagnostic technologies, incorporation of machine learning, investments funnelled towards research and development, embracing of telemedicine, and obtaining regulatory approvals for faster market access.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24460&type=smp

#What Drivers Are Influencing Growth In The Angioedema Treatment Market?

The angioedema treatment market is anticipated to expand due to a surge in the instances of rare illnesses. Such diseases, which affect only a tiny fraction of the population, usually have limited therapeutic options and can significantly impact health. Thanks to advancements in genetic testing and diagnostic techniques, the ability to identify and correctly diagnose previously unrecognized conditions has increased — leading to increased reported prevalence of these conditions. In treating uncommon disorders like hereditary angioedema, angioedema therapy offers specialized treatments that prevent and control severe swelling episodes, thereby improving patient outcomes. As an example, in November 2024, the US federal agency, Food and Drug Administration, reported that over 7,000 rare diseases affected more than 30 million people in the United States. Accordingly, the escalating incidence of rare diseases is fueling the growth of the angioedema treatment market.

What Are The Main Segments Identified In The Angioedema Treatment Market Research?

The angioedema treatment market covered in this report is segmented –

1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema

2) By Route Of Administration: Injection, Oral

3) By End Use: Hospitals, Clinics, Research Organizations

1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies

2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors

3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management

4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics

What Are The Leading Trends And Opportunities In The Angioedema Treatment Sector?

Leading corporations in the angioedema treatment sector are striving to innovate new solutions like subcutaneous injections, aiming to provide fast and easy relief for patients enduring acute hereditary angioedema (HAE) attacks. This injection method allows for the steady and slow absorption of medication into the blood through the fatty tissue under the skin. For example, in April 2025, the Australian biotech firm, CSL Limited, introduced a unique, fully human monoclonal antibody treatment for acute attacks prevention in HAE patients. The new drug, ANDEMBRY (garadacimab), is the pioneer pre-filled pen for once-monthly subcutaneous usage, providing a convenient option for long-term prevention. The drug operates by inhibiting Factor XII (Factor XIIa), a principle precursor in the angioedema sequence, thus marking a significant improvement in HAE management through providing efficient patient-centric disease control.

Which Companies Play A Key Role In The Development Of The Angioedema Treatment Market?

Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/angioedema-treatment-global-market-report

What Are The Key Regional Developments Shaping The Angioedema Treatment Market?

North America was the largest region in the angioedema treatment market in 2024. The regions covered in the angioedema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24460&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Angioedema Treatment Market?

There has been a fast-paced expansion in the angioedema treatment market size lately. The market is projected to rise from $2.72 billion in 2024 to $3.13 billion in 2025, with an annual compound growth rate (CAGR) of 15.0%. Factors contributing to this growth during the historic period include an increase in governmental support, higher diagnosis rates, a surge in autoimmune disorders, expansion in clinical trial activity, and the development of healthcare infrastructure.

What Growth Rate Is Forecasted for the Angioedema Treatment Market by 2029?

The market for angioedema treatment is projected to experience a swift expansion in the coming years. It is predicted to reach a value of $5.4 billion by 2029, with a 14.6% compound annual growth rate (CAGR). The expected growth during the forecast period is due to a rise in healthcare spending, increased consciousness about allergies, a growing incidence of chronic illnesses, a heightened occurrence and prevalence of angioedema, and an intensified focus on individualized medicine. Key trends to expect during this period include progress in diagnostic technologies, the merging of machine learning, investment in research and development, the implementation of telemedicine, and the ease of regulatory approvals leading to faster market penetration.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24460&type=smp

Which Key Companies Are Shaping the Future of the Angioedema Treatment Market?

Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

Which Factors Are Driving Demand in the Angioedema Treatment Industry?

The expected increase in rare disease cases is predicted to fuel the angioedema treatment market’s expansion. Rare diseases are medical conditions that only impact a minute part of the population and usually come with limited cure options and significant health influence. With the evolution of genetic testing and diagnostic technologies, the recognition and accurate diagnosis of these rare diseases, which were previously unobserved, are now possible. This trend has led to an increased reported prevalence. Treating angioedema is beneficial for rare diseases like hereditary angioedema as it provides specialized therapies to prevent and manage serious swelling incidents, thereby enhancing patient outcomes. For example, as reported by the US-based federal agency, Food and Drug Administration, over 7,000 rare diseases affected more than 30 million individuals in the United States as of November 2024. Thus, the angioedema treatment market is being propelled by the escalating incidence of these rare diseases.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24460&type=smp

How Is the Angioedema Treatment Market Segmented by Several Divisions?

The angioedema treatment market covered in this report is segmented –

1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema

2) By Route Of Administration: Injection, Oral

3) By End Use: Hospitals, Clinics, Research Organizations

1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies

2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors

3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management

4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics

What are the Emerging Market Trends Driving the Growth of the Angioedema Treatment Industry?

Key players in the angioedema treatment market are concentrating their efforts on creating innovative remedies like subcutaneous injections to provide quicker and more comfortable relief for individuals suffering from severe hereditary angioedema (HAE) episodes. Subcutaneous injections, which deliver medication into the fatty tissue just under the skin, allow for consistent and gradual dissemination into the bloodstream. For example, in April 2025, CSL Limited, a biotechnology firm based in Australia, launched ANDEMBRY (garadacimab), a novel, fully human monoclonal antibody therapy used to prevent severe episodes in patients with hereditary angioedema (HAE). ANDEMBRY is the first pre-filled pen for monthly subcutaneous use, providing a convenient option for long-term prevention. The medicine achieves its effects by hindering activated Factor XII (Factor XIIa), a critical starter in the cascade resulting in angioedema, symbolizing a remarkable progress in HAE management by offering effective, patient-oriented disease control.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/angioedema-treatment-global-market-report

Which Regions Are Driving Growth in the Angioedema Treatment Market?

North America was the largest region in the angioedema treatment market in 2024. The regions covered in the angioedema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24460

This Report Delivers Insight On:

1. How big is the angioedema treatment market, and how is it changing globally?

2. Who are the major companies in the angioedema treatment market, and how are they performing?

3. What are the key opportunities and risks in the angioedema treatment market right now?

4. Which products or customer segments are growing the most in the angioedema treatment market?

5. What factors are helping or slowing down the growth of the angioedema treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model